A pioneering home-treatment approach being adopted by nurses at a Scottish hospital is transforming the lives of teenagers ...

Learn how ulcerative colitis affects your chances of getting the common cold or flu, and what you can do to treat or prevent ...

Common medications used to treat ulcerative colitis, such as 5-aminosalycates, biologics, steroids, and JAK inhibitors, can cause unwanted side effects.

We live in an age where information is instant. A quick Google search can bring up millions of results in seconds. But along ...

Stifel Virtual Immunology and Inflammation Forum September 16, 2025 12:30 PM EDTCompany ParticipantsMartin Babler - President, ...

Navigator Medicines Announces Positive Phase 1a Data from its Program of Potential Best-in-Class Bispecific Antibodies; NAV-240 Poised for Further Development in Inflammatory Disorders and Autoimmune ...

One-day intensive course boosted first-year trainees’ overall confidence in IBD and raised comfort levels in discussing ...

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the potential of tumor necrosis factor-like ligand 1A ...

Among patients with IBD, HLA-B27 positivity and higher UC disease activity were associated with an increased risk for SpA.

UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).

The findings could help explain why for many individuals with Crohn’s disease patients, anti-inflammatories aren’t sufficient to stop the disease.

The guideline was developed in line with internationally recognized standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD's newly established Standard ...